NUCLEOLIN and cancer: An attractive target for TNBC therapy is NCL, a nucleocytoplasmic protein involved in several biological processes, such as ribosomal assembly, rRNA processing, mRNA stability and miRNAs biogenesis, strongly associated with tumor development and aggressiveness, which is selectively expressed on the surface of cancer cells, but not on their normal counterparts [77].